Cargando…
Moyamoya Disease: When Should You Look for a Genetic Cause of Stroke?
INTRODUCTION: Strokes are common but can be caused by a rare illness. Moyamoya disease (MMD) justifies a family assessment because of its hereditary nature and the availability of new therapies. CASE DESCRIPTION: A 42-year-old man was admitted because of convulsions with sensorimotor deficit due to...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SMC Media Srl
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067414/ https://www.ncbi.nlm.nih.gov/pubmed/35520361 http://dx.doi.org/10.12890/2022_003298 |
_version_ | 1784700000932986880 |
---|---|
author | Van Overstraeten, Chloé |
author_facet | Van Overstraeten, Chloé |
author_sort | Van Overstraeten, Chloé |
collection | PubMed |
description | INTRODUCTION: Strokes are common but can be caused by a rare illness. Moyamoya disease (MMD) justifies a family assessment because of its hereditary nature and the availability of new therapies. CASE DESCRIPTION: A 42-year-old man was admitted because of convulsions with sensorimotor deficit due to a massive cerebral haemorrhage caused by MMD. The fact that the patient died suggested his children should be screened. DISCUSSION: MMD is rare and its consequences disastrous. Many cases in both children and adults have been described. Investigations should be carried out when the diagnosis is suspected, and, if confirmed, the family should be screened given the genetic nature of some forms of the disease. Effective and increasingly personalized therapeutic solutions are available. CONCLUSIONS: A minority of strokes are caused by rare diseases including MMD. Our current knowledge of this pathology and the treatments available justify a family assessment when the clinical or family context requires it. LEARNING POINTS: Strokes are frequent but can reveal rare conditions, including Moyamoya disease. The families of patients should be screened in order to avoid morbidity and mortality. The diagnosis is not necessarily fatal as there are various promising therapeutic solutions, which should encourage further research. |
format | Online Article Text |
id | pubmed-9067414 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | SMC Media Srl |
record_format | MEDLINE/PubMed |
spelling | pubmed-90674142022-05-04 Moyamoya Disease: When Should You Look for a Genetic Cause of Stroke? Van Overstraeten, Chloé Eur J Case Rep Intern Med Article INTRODUCTION: Strokes are common but can be caused by a rare illness. Moyamoya disease (MMD) justifies a family assessment because of its hereditary nature and the availability of new therapies. CASE DESCRIPTION: A 42-year-old man was admitted because of convulsions with sensorimotor deficit due to a massive cerebral haemorrhage caused by MMD. The fact that the patient died suggested his children should be screened. DISCUSSION: MMD is rare and its consequences disastrous. Many cases in both children and adults have been described. Investigations should be carried out when the diagnosis is suspected, and, if confirmed, the family should be screened given the genetic nature of some forms of the disease. Effective and increasingly personalized therapeutic solutions are available. CONCLUSIONS: A minority of strokes are caused by rare diseases including MMD. Our current knowledge of this pathology and the treatments available justify a family assessment when the clinical or family context requires it. LEARNING POINTS: Strokes are frequent but can reveal rare conditions, including Moyamoya disease. The families of patients should be screened in order to avoid morbidity and mortality. The diagnosis is not necessarily fatal as there are various promising therapeutic solutions, which should encourage further research. SMC Media Srl 2022-04-06 /pmc/articles/PMC9067414/ /pubmed/35520361 http://dx.doi.org/10.12890/2022_003298 Text en © EFIM 2022 This article is licensed under a Commons Attribution Non-Commercial 4.0 License |
spellingShingle | Article Van Overstraeten, Chloé Moyamoya Disease: When Should You Look for a Genetic Cause of Stroke? |
title | Moyamoya Disease: When Should You Look for a Genetic Cause of Stroke? |
title_full | Moyamoya Disease: When Should You Look for a Genetic Cause of Stroke? |
title_fullStr | Moyamoya Disease: When Should You Look for a Genetic Cause of Stroke? |
title_full_unstemmed | Moyamoya Disease: When Should You Look for a Genetic Cause of Stroke? |
title_short | Moyamoya Disease: When Should You Look for a Genetic Cause of Stroke? |
title_sort | moyamoya disease: when should you look for a genetic cause of stroke? |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067414/ https://www.ncbi.nlm.nih.gov/pubmed/35520361 http://dx.doi.org/10.12890/2022_003298 |
work_keys_str_mv | AT vanoverstraetenchloe moyamoyadiseasewhenshouldyoulookforageneticcauseofstroke |